-
Symbol
-
ALGS on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
176K shares
-
Security Ownership
-
3.2%
Lawrence M. Blatt, Ph.D. ownership in Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share (ALGS)
2025-03-12 - Lawrence M. Blatt, Ph.D. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 176K shares of Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share (ALGS).
This represents 3.2% percent ownership of the company.